We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NXST:NASDAQNexstar Media Group, Inc. Analysis

Data as of 2026-04-21 - not real-time

$208.65

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Nexstar (NXST) is trading at $208.65, comfortably above its 20‑day SMA ($195.34) and 200‑day SMA ($204.09) but below the 50‑day SMA ($221.19), indicating a short‑term bullish tilt within a neutral longer‑term trend. The RSI sits at 54 and the MACD histogram is positive, reinforcing modest upside momentum, while volume has been declining and 30‑day volatility is high at 54%, suggesting price swings may be pronounced. Valuation metrics are mixed: a trailing P/E of 69.5 far exceeds the industry average of 19.2, yet the forward P/E of 11.6 and a DCF‑derived fair value of $213.5 imply the stock may be nearing its intrinsic worth, with a calculated upside of roughly 25%. Dividend sustainability is a concern as the 3.62% yield is backed by a payout ratio of 248%, well above sustainable levels.
The recent closure of the TEGNA acquisition and the issuance of $5.1 B in senior notes dramatically increase leverage, pushing the debt‑to‑equity ratio above 300 and raising balance‑sheet risk. Insider sales by senior executives further temper confidence. However, operating margins remain solid (20.5% operating, 2.2% net) and free cash flow is positive, providing a cushion for integration. With the market in “Extreme Greed” mode (Fear & Greed Index 86) and analysts averaging a “strong buy” rating, the stock sits at a crossroads between short‑term volatility and longer‑term strategic upside.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Positive MACD histogram and price above short‑term SMA
  • High short‑term volatility and decreasing volume
  • Pending Q1 earnings and integration risk from TEGNA deal

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward P/E compression to 11.6 indicating earnings growth
  • DCF upside of ~25% and fair value near current price
  • Strategic scale benefits from TEGNA acquisition

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Elevated leverage and unsustainable dividend payout
  • Stable operating margins and positive free cash flow
  • Potential regulatory and integration headwinds

Key Metrics & Analysis

Financial Health

Revenue Growth-13.30%
Profit Margin2.20%
P/E Ratio69.5
ROE3.83%
ROA5.01%
Debt/Equity320.85
P/B Ratio3.1
Op. Cash Flow$891.0M
Free Cash Flow$941.9M
Industry P/E19.2

Technical Analysis

TrendNeutral
RSI54.0
Support$173.02
Resistance$228.67
MA 20$195.34
MA 50$221.19
MA 200$204.09
MACDBullish
VolumeDecreasing
Fear & Greed Index86.14

Valuation

Fair Value$213.50
Target Price$261.25
Upside/Downside25.21%
GradeFair
TypeBlend
Dividend Yield3.62%

Risk Assessment

Beta0.68
Volatility54.04%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.